| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.095 | 0.04 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.095 | 0.05 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.097 | 0.07 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.089 | 0.08 |